Novel antibiotic screening methods to awaken silent or cryptic secondary metabolic pathways in actinomycetes

Journal of Antibiotics

Volumn 70, Issue 8, 2017, Pages 865-870

  Onaka, Hiroyasu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; GOADSPORIN; MYCOLIC ACID; SYNTHETIC DNA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PEPTIDE;

ACTINOBACTERIA; ANTIBIOTIC RESISTANCE; ARTICLE; COCULTURE; DRUG SCREENING; GENE CLUSTER; GROWTH INHIBITION; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; SECONDARY METABOLISM; SPOROGENESIS; STREPTOMYCES LIVIDANS; TSUKAMURELLA PULMONIS; DRUG DEVELOPMENT; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MULTIGENE FAMILY; PROCEDURES; STREPTOMYCES;

ANTI-BACTERIAL AGENTS; COCULTURE TECHNIQUES; DRUG DISCOVERY; MULTIGENE FAMILY; PEPTIDES; SECONDARY METABOLISM; STREPTOMYCES;

EID: 85026395809     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2017.51     Document Type: Article

References (23)

1. Cragg G. M, & Newman D. J. Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta. 1830, 3670-3695 (2013).
2. Nett M, Ikeda H, & Moore B. S. Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat. Prod. Rep. 26, 1362-1384 (2009).
3. Scherlach K, & Hertweck C. Triggering cryptic natural product biosynthesis in microorganisms. Org. Biomol. Chem. 7, 1753-1760 (2009).
4. Zarins-Tutt J. S, et al. Prospecting for new bacterial metabolites: a glossary of approaches for inducing, activating and upregulating the biosynthesis of bacterial cryptic or silent natural products. Nat. Prod. Rep. 33, 54-72 (2016).
5. Ochi K. Insights into microbial cryptic gene activation and strain improvement: principle, application and technical aspects. J. Antibiot. (Tokyo) 70, 25-40 (2017).
6. Horinouchi S, & Beppu T. Hormonal control by A-factor of morphological development and secondary metabolism in Streptomyces. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 83, 277-295 (2007).
7. Onaka H, Tabata H, Igarashi Y, Sato Y, & Furumai T. Goadsporin a chemical substance which promotes secondary metabolism and morphogenesis in streptomycetes. I. Purification and characterization. J. Antibiot. (Tokyo) 54, 1036-1044 (2001).
8. Igarashi Y, et al. Goadsporin, a chemical substance which promotes secondary metabolism and morphogenesis in streptomycetes. II. Structure determination. J. Antibiot. (Tokyo) 54, 1045-1053 (2001).
9. Onaka H, Nakaho M, Hayashi K, Igarashi Y, & Furumai T. Cloning and characterization of the goadsporin biosynthetic gene cluster from Streptomyces sp. TP-A0584. Microbiology 151(Pt 12), 3923-3933 (2005).
10. Ozaki T, et al. Insights into the biosynthesis of dehydroalanines in goadsporin. Chembiochem 17, 218-223 (2016).
11. Ozaki T, et al. Dissection of goadsporin biosynthesis by in vitro reconstitution leading to designer analogs expressed in vivo. Nat. Commun. 8, 14207 (2017).
12. Haginaka K, et al. Genetic approaches to generate hyper-producing strains of goadsporin: the relationships between productivity and gene duplication in secondary metabolite biosynthesis. Biosci. Biotechnol. Biochem. 78, 394-399 (2014).
13. Onaka H, Mori Y, Igarashi Y, & Furumai T. Mycolic acid-containing bacteria induce natural-product biosynthesis in Streptomyces species. Appl. Environ. Microbiol. 77, 400-406 (2011).
14. Igarashi Y, et al. Alchivemycin A, a bioactive polycyclic polyketide with an unprecedented skeleton from Streptomyces sp. Org. Lett. 12, 3402-3405 (2010).
15. Kim Y, In Y, Ishida T, Onaka H, & Igarashi Y. Biosynthetic origin of alchivemycin A, a new polyketide from Streptomyces and absolute configuration of alchivemycin B. Org. Lett. 15, 3514-3517 (2013).
16. Hoshino S, et al. Arcyriaflavin E, a new cytotoxic indolocarbazole alkaloid isolated by combined-culture of mycolic acid-containing bacteria and Streptomyces cinnamoneus NBRC 13823. J. Antibiot. (Tokyo) 68, 342-344 (2015).
17. Hoshino S, Wakimoto T, Onaka H, Abe I, & Chojalactones A.-C. cytotoxic butanolides isolated from Streptomyces sp. cultivated with mycolic acid containing bacterium. Org. Lett. 17, 1501-1504 (2015).
18. Sugiyama R, et al. 5-Alkyl-1, 2, 3, 4-Tetrahydroquinolines, new membrane-interacting lipophilic metabolites produced by combined culture of Streptomyces nigrescens and Tsukamurella pulmonis. Org. Lett. 17, 1918-1921 (2015).
19. Sugiyama R, et al. Discovery and total synthesis of streptoaminals: antimicrobial [5, 5]-spirohemiaminals from the combined-culture of Streptomyces nigrescens and Tsukamurella pulmonis. Angew. Chem. Int. Ed. Engl. 55, 10278-10282 (2016).
20. Derewacz D. K, Covington B. C, McLean J. A, & Bachmann B. O. Mapping microbial response metabolomes for induced natural product discovery. ACS Chem. Biol. 10, 1998-2006 (2015).
21. Onaka H, et al. Mycolic acid-containing bacteria activate heterologous secondary metabolite expression in Streptomyces lividans. J. Antibiot. (Tokyo) 68, 594-597 (2015).
22. Asamizu S, Ozaki T, Teramoto K, Satoh K, & Onaka H. Killing of mycolic acidcontaining bacteria aborted induction of antibiotic production by streptomyces in combined-culture. PLoS ONE 10, e0142372 (2015).
23. Bertrand S, et al. Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery. Biotechnol Adv. 32, 1180-1204 (2014).